Inflectra and Weight gain poor - a phase IV clinical study of FDA data

Summary:

Weight gain poor is reported as a side effect among people who take Inflectra (infliximab-dyyb), especially for people who are female, 40-49 old, also take Prednisone, and have Crohn's disease.

The phase IV clinical study analyzes which people have Weight gain poor when taking Inflectra. It is created by eHealthMe based on reports of 52,342 people who have side effects when taking Inflectra from the FDA, and is updated regularly.

What is Inflectra?

Inflectra has active ingredients of infliximab-dyyb. eHealthMe is studying from 52,370 Inflectra users. Check the latest studies of Inflectra.

What is Weight gain poor?

Weight gain poor is found to be associated with 297 drugs and 541 conditions by eHealthMe. Check the latest studies of Weight gain poor.

On Aug, 06, 2026

52,342 people reported to have side effects when taking Inflectra.
Among them, 11 people (0.02%) have Weight gain poor.

Among these 11 people:

What is the gender of people who have Weight gain poor when taking Inflectra? *

female: 100 %
male: 0.0 %

What is the age of people who have Weight gain poor when taking Inflectra? *

What are other drugs people take besides Inflectra? *

What are other side effects people have besides Weight gain poor? *

Haematochezia (passage of stools containing blood): 8 people, 72.73%
Weight Decreased: 6 people, 54.55%
High Blood Pressure: 6 people, 54.55%
Constipation: 6 people, 54.55%
Paraesthesia Oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect): 6 people, 54.55%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 6 people, 54.55%
Maternal Exposure During Pregnancy (use of substance during pregnancy): 4 people, 36.36%
Nausea (feeling of having an urge to vomit): 3 people, 27.27%
Coccydynia (pain in the coccyx or tailbone area): 2 people, 18.18%
Faeces Hard: 2 people, 18.18%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 9 people, 81.82%
Thrombosis (formation of a blood clot inside a blood vessel): 6 people, 54.55%
High Blood Pressure: 6 people, 54.55%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 6 people, 54.55%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Inflectra and have Weight gain poor?

- Check whether Weight gain poor is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Inflectra:

Inflectra (52,370 reports)

Browse all side effects of Inflectra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight gain poor:

Weight gain poor (297 drugs)

Browse all the conditions that are associated with Weight gain poor:

Weight gain poor (541 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab-dyyb (the active ingredients of Inflectra) and Inflectra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.